Showing 18,241 - 18,260 results of 101,596 for search '(( 2 nn decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.86s Refine Results
  1. 18241
  2. 18242

    Mutations altering LTD dynamics impair their lipid transport properties (a) Design of the STARD11-5P mutant at the omega loop (pink). by Sriraksha Srinivasan (7535654)

    Published 2024
    “…<b>(f)</b> Mass spectrometry profile of major sphingomyelins in HeLa cells; Hela cells <i>STARD11</i>-KO, and Hela cells <i>STARD11</i>-KO overexpressing STARD11-GFP WT (wt) or the STARD11-5P-GFP (5P) mutant. (<i>n</i> = 3; data are means ± SD; *<i>p</i> < 0.05, **<i>p</i> < 0.01; ***<i>p</i> < 0.001 [ordinary one-way ANOVA]). …”
  3. 18243
  4. 18244

    Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [<sup>18</sup>F]ENL30: A Potential PET Radiotracer for the 5‑HT<sub>7</sub> Receptor by Elina Tampio L’Estrade (6619937)

    Published 2019
    “…The 5-HT<sub>7</sub> receptor (5-HT<sub>7</sub>R) is involved in a broad range of physiological conditions and disorders. …”
  5. 18245

    Evaluation of PNA effect on CD5 expression. by Elena Cesaro (11424301)

    Published 2022
    “…Cells transfected with <b>PNA</b> showed a decreased CD5 mRNA expression, differently from cells transfected with <b>scrambled PNA</b> used as negative control. …”
  6. 18246
  7. 18247

    Ybx1 regulation of its target mRNAs is m<sup>5</sup>C-depdendent (Related to Fig 5). by Jian Zhang (1682)

    Published 2025
    “…<p><b>(A)</b> RT-qPCR confirmed the decreased expression levels of Ybx1 target mRNAs in neural stem cells with Ybx1 knockdown using siRNA. …”
  8. 18248
  9. 18249

    Neuroimaging findings. by Irene Flønes (849434)

    Published 2016
    “…C (upper lane): FDG-PET scan of the brain of patient 1 taken ~5 years later shows multiple foci of decreased glucose metabolism that correlate to the localization of the transient cortical signal changes on MRI. …”
  10. 18250
  11. 18251
  12. 18252
  13. 18253
  14. 18254

    The Natural Anticancer Agent Plumbagin Induces Potent Cytotoxicity in MCF-7 Human Breast Cancer Cells by Inhibiting a PI-5 Kinase for ROS Generation by Ju-Hee Lee (135452)

    Published 2012
    “…In MCF7 human breast cancer cells, plumbagin significantly decreased the level of a human ortholog, 1, 4-phopshatidylinositol 5-kinase (PI5K)-1B, of yeast its3, and knockdown of PI5K-1B using siPI5K-1B increased the ROS level and decreased cell viability. …”
  15. 18255

    Table_5_Which Factors Affect the Occurrence of Off-Target Effects Caused by the Use of CRISPR/Cas: A Systematic Review in Plants.XLSX by Dominik Modrzejewski (5639621)

    Published 2020
    “…In addition, we ran a binary logistic regression analysis to verify five factors that may affect the occurrence of off-target effects: (1) Number of mismatches (2) Position of mismatches (3) GC-content of the targeting sequence (4) Altered nuclease variants (5) Delivery methods. …”
  16. 18256

    Image_5_Effects of dietary supplement with a Chinese herbal mixture on growth performance, antioxidant capacity, and gut microbiota in weaned pigs.PDF by Qinglei Xu (8497341)

    Published 2022
    “…A total of 400 weaned pigs [Duroc × (Landrace × Yorkshire)] were randomly allocated into one of four treatments: the CON group, fed with basic diet; the HM1 group, fed with basal diet supplemented with 0.5 g herbal mixture/kg diet; the HM2 group, fed with basal diet supplemented with 1.0 g herbal mixture/kg diet; or the HM3 group, fed with basal diet supplemented with 1.5 g herbal mixture/kg diet. …”
  17. 18257
  18. 18258

    Impaired fibronectin and fibrinogen-cleaving activities of the E143A and H146A Zmp1 mutants. by Valeria Cafardi (490077)

    Published 2013
    “…(<b>C</b>) Decreased ability of E143A and H146A Zmp1 mutants to cleave fibronectin. 1 µM fibronectin from human plasma was incubated for 24 h at 37°C with no Zmp1 (control) or with 7.7 µM of wild type (WT), E143A or H146A Zmp1 in the presence of 0.5 mM ZnCl<sub>2</sub>. 1 µg of fibronectin was analyzed by SDS-PAGE and Coomassie-blue staining. …”
  19. 18259

    FIGURE 5 from Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor by Shruti Lal (16805936)

    Published 2023
    “…<p>Phosphoproteomic screen identifies MCM2 Ser108 phosphorylation decreased by ZL-2201. <b>A,</b> Simple Western showing inhibition of pDNA-PK upon treatment with PRKDC siRNA, 300 nmol/L and 3.5 μmol/L of ZL-2201 ± 10 μmol/L bleomycin used in phospho-MS screen analysis. …”
  20. 18260